• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将简单线性组合、多元逻辑回归和因子分析方法应用于候选粪便细菌,以寻找用于早期检测腺瘤性息肉和结肠癌的新型生物标志物。

Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.

作者信息

Rezasoltani Sama, Sharafkhah Maryam, Asadzadeh Aghdaei Hamid, Nazemalhosseini Mojarad Ehsan, Dabiri Hossein, Akhavan Sepahi Abbas, Modarressi Mohammad Hossein, Feizabadi Mohammad Mehdi, Zali Mohammad Reza

机构信息

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

J Microbiol Methods. 2018 Dec;155:82-88. doi: 10.1016/j.mimet.2018.11.007. Epub 2018 Nov 12.

DOI:10.1016/j.mimet.2018.11.007
PMID:30439465
Abstract

BACKGROUND

Colorectal cancer (CRC) is the third leading cause of cancer, and presents a considerable disease burden, worldwide. Recently, the gut microbiota has been proposed as a potential risk factor for CRC, and even adenomatous polyps (AP). Here, the aim of this study was to investigate the role of selected gut bacteria as fecal bacterial biomarkers, in early detection of CRC and AP.

MATERIAL AND METHODS

Fecal samples (n = 93) were collected from Taleghani Hospital, Tehran, Iran, between 2015 and 2017, from normal controls (NC), AP cases and CRC stage I patients, who were undergoing screening for colonoscopy. Absolute quantitative real time PCR (qPCR) assays were established for the quantification of bacterial marker candidates, in all cases and control groups. In order to evaluate the diagnostic value of bacterial candidates in distinguishing CRC from a polyp, receiver operating characteristic curve (ROC) was performed. Multiple logistic regressions were used to find the best combinations of the bacterial candidates, then, combinations were analyzed based on three methods, including linear combination, multiple logistic and factor analysis models.

RESULTS

According to the logistic model, combination of Fusobacterium nucleatum, Enterococcus feacalis, Streptococcus bovis, Enterotoxigenic Bacteroides fragilis (ETBF) and Porphyromonas spp. showed improved diagnostic performance, compared to each bacterium alone, as area under the receiver operating characteristic (AUROC) increases to 0.97, with 95% confidence interval. It was found that a simple linear combination was an appropriate model for discriminating AP and CRC cases, compared to the NC, with a sensitivity of 91.4% and specificity of 93.5%.

CONCLUSION

Our results indicated that based on fecal bacterial candidates, statistical simple linear combination model and ROC curve analysis, early detection of AP and CRC might be possible.

摘要

背景

结直肠癌(CRC)是全球第三大癌症死因,带来了相当大的疾病负担。最近,肠道微生物群被认为是CRC甚至腺瘤性息肉(AP)的潜在危险因素。本研究旨在探讨特定肠道细菌作为粪便细菌生物标志物在CRC和AP早期检测中的作用。

材料与方法

2015年至2017年间,从伊朗德黑兰塔莱哈尼医院收集了93份粪便样本,样本来自接受结肠镜筛查的正常对照(NC)、AP病例和CRC I期患者。对所有病例组和对照组建立了绝对定量实时PCR(qPCR)检测方法,用于定量细菌标志物候选物。为了评估细菌候选物在区分CRC和息肉方面的诊断价值,绘制了受试者工作特征曲线(ROC)。采用多元逻辑回归寻找细菌候选物的最佳组合,然后基于线性组合、多元逻辑和因子分析模型三种方法对组合进行分析。

结果

根据逻辑模型,具核梭杆菌、粪肠球菌、牛链球菌、产肠毒素脆弱拟杆菌(ETBF)和卟啉单胞菌属的组合显示出比单一细菌更好的诊断性能,受试者工作特征曲线下面积(AUROC)增加到0.97,95%置信区间。结果发现,与NC相比,简单线性组合是区分AP和CRC病例的合适模型,灵敏度为91.4%,特异性为93.5%。

结论

我们的结果表明,基于粪便细菌候选物、统计简单线性组合模型和ROC曲线分析,可能实现AP和CRC的早期检测。

相似文献

1
Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.将简单线性组合、多元逻辑回归和因子分析方法应用于候选粪便细菌,以寻找用于早期检测腺瘤性息肉和结肠癌的新型生物标志物。
J Microbiol Methods. 2018 Dec;155:82-88. doi: 10.1016/j.mimet.2018.11.007. Epub 2018 Nov 12.
2
The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer.粪便微生物群与不同类型结直肠息肉作为结直肠癌前体的关系。
Microb Pathog. 2018 Nov;124:244-249. doi: 10.1016/j.micpath.2018.08.035. Epub 2018 Aug 22.
3
Fecal Bacteria Act as Novel Biomarkers for Noninvasive Diagnosis of Colorectal Cancer.粪便细菌可作为结直肠癌无创诊断的新型生物标志物。
Clin Cancer Res. 2017 Apr 15;23(8):2061-2070. doi: 10.1158/1078-0432.CCR-16-1599. Epub 2016 Oct 3.
4
Accuracy of the Discriminatory Ability of Combined Fecal Microbiota Panel in the Early Detection of Patients with Colorectal Cancer.粪便微生物组合panel 早期检测结直肠癌患者的鉴别能力的准确性。
J Gastrointest Cancer. 2024 Mar;55(1):332-343. doi: 10.1007/s12029-023-00962-z. Epub 2023 Aug 11.
5
The Role of Fecal and as Early Diagnostic Markers of Colorectal Cancer.粪便 和 的作用:结直肠癌的早期诊断标志物。
Dis Markers. 2021 Nov 22;2021:1171239. doi: 10.1155/2021/1171239. eCollection 2021.
6
Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer.粪便M2型丙酮酸激酶作为结直肠癌诊断标志物的评估
J Gastrointest Cancer. 2019 Sep;50(3):442-450. doi: 10.1007/s12029-018-0088-1.
7
Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.利用高通量实时聚合酶链反应在外周血单个核细胞中发现用于检测结直肠癌和腺瘤的29基因检测板。
PLoS One. 2015 Apr 13;10(4):e0123904. doi: 10.1371/journal.pone.0123904. eCollection 2015.
8
Classification of Changes in the Fecal Microbiota Associated with Colonic Adenomatous Polyps Using a Long-Read Sequencing Platform.基于长读测序平台的结直肠腺瘤性息肉相关粪便微生物群变化分类。
Genes (Basel). 2020 Nov 20;11(11):1374. doi: 10.3390/genes11111374.
9
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.LGALS4、CEACAM6、TSPAN8 和 COL1A2:粪便免疫化学检测结果阳性受试者队列中的结直肠癌血液标志物——验证研究。
Clin Colorectal Cancer. 2018 Jun;17(2):e217-e228. doi: 10.1016/j.clcc.2017.12.002. Epub 2017 Dec 12.
10
The association between fecal enterotoxigenic B. fragilis with colorectal cancer.脆弱拟杆菌肠毒素与结直肠癌的相关性。
BMC Cancer. 2019 Sep 5;19(1):879. doi: 10.1186/s12885-019-6115-1.

引用本文的文献

1
FadA antigen of Fusobacterium nucleatum: implications for ceRNA network in colorectal cancer and adenomatous polyps progression.具核梭杆菌的FadA抗原:对结直肠癌和腺瘤性息肉进展中ceRNA网络的影响
Discov Oncol. 2025 Jan 18;16(1):58. doi: 10.1007/s12672-025-01796-w.
2
Sugar Composition of Thai Desserts and Their Impact on the Gut Microbiome in Healthy Volunteers: A Randomized Controlled Trial.泰国甜点的糖组成及其对健康志愿者肠道微生物组的影响:一项随机对照试验。
Nutrients. 2024 Nov 18;16(22):3933. doi: 10.3390/nu16223933.
3
From pathogenesis to treatment: the impact of bacteria on cancer.
从发病机制到治疗:细菌对癌症的影响
Front Microbiol. 2024 Sep 18;15:1462749. doi: 10.3389/fmicb.2024.1462749. eCollection 2024.
4
16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population.伊朗人群中结直肠癌阳性与结直肠癌阴性患者口腔和粪便微生物群的16S rRNA测序分析
Gut Pathog. 2024 Feb 20;16(1):9. doi: 10.1186/s13099-024-00604-0.
5
Accuracy of the Discriminatory Ability of Combined Fecal Microbiota Panel in the Early Detection of Patients with Colorectal Cancer.粪便微生物组合panel 早期检测结直肠癌患者的鉴别能力的准确性。
J Gastrointest Cancer. 2024 Mar;55(1):332-343. doi: 10.1007/s12029-023-00962-z. Epub 2023 Aug 11.
6
Gut microbiota bridges the iron homeostasis and host health.肠道微生物群架起铁平衡和宿主健康之间的桥梁。
Sci China Life Sci. 2023 Sep;66(9):1952-1975. doi: 10.1007/s11427-022-2302-5. Epub 2023 Jul 27.
7
Fecal Microbiota and Associated Volatile Organic Compounds Distinguishing No-Adenoma from High-Risk Colon Adenoma Adults.粪便微生物群及相关挥发性有机化合物对无腺瘤与高危结肠腺瘤成年人的鉴别作用
Metabolites. 2023 Jul 4;13(7):819. doi: 10.3390/metabo13070819.
8
Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.肠道微生物组及其代谢组学在结直肠癌早期筛查中的研究进展。
Clin Transl Oncol. 2023 Jul;25(7):1949-1962. doi: 10.1007/s12094-023-03097-6. Epub 2023 Feb 15.
9
Oral Microbiota as Novel Biomarkers for Colorectal Cancer Screening.口腔微生物群作为结直肠癌筛查的新型生物标志物
Cancers (Basel). 2022 Dec 28;15(1):192. doi: 10.3390/cancers15010192.
10
Evaluating the predictive performance of gut microbiota for the early-stage colorectal cancer.评估肠道微生物群对早期结直肠癌的预测性能。
BMC Gastroenterol. 2022 Dec 12;22(1):514. doi: 10.1186/s12876-022-02599-x.